2. Academic Validation
  3. Novel Pyridopyrazine Derivatives as Inverse Agonists of the G Protein-Coupled Receptor 6

Novel Pyridopyrazine Derivatives as Inverse Agonists of the G Protein-Coupled Receptor 6

  • ACS Med Chem Lett. 2026 Jan 13;17(2):280-281. doi: 10.1021/acsmedchemlett.5c00748.
Yinlong Li 1,  Steven H Liang 1 2
Affiliations

Affiliations

  • 1 Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.
  • 2 Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332, United States.
PMID: 41704355 DOI: 10.1021/acsmedchemlett.5c00748
Abstract

This patent highlight describes the development and evaluation of novel pyridopyrazine analogs as potent inverse agonists for G protein-coupled receptor 6 (GPR6). It discloses synthetic methods and pharmacological properties of these new GPR6 modulators.

Figures
Products